Identification and Characterization of Antigenically Advanced Variants to Accelerate and Improve Influenza Vaccine Development

This contract involves a forecasted project with the University of Wisconsin focusing on the identification and characterization of antigenically advanced influenza virus variants. The primary objective is to accelerate and enhance influenza vaccine development by studying these evolving virus strains to better understand their antigenic properties. The initiative is overseen by the Centers for Disease Control and Prevention (CDC), reflecting a public health-driven effort to improve vaccine efficacy and preparedness against influenza outbreaks. Key contacts for the project include Charmaine Mckenzie as the program point of contact and a contracting officer whose identity is yet to be determined. Although specific solicitation details such as location and NAICS codes are not provided, the contract aligns with the CDC's mission to support research and development activities that contribute to disease prevention and control. This effort underscores the importance of innovative scientific strategies in addressing the challenges posed by rapidly mutating influenza viruses.